《Chinese Journal of Rehabilitation Theory and Practice》 ›› 2019, Vol. 25 ›› Issue (12): 1434-1438.doi: 10.3969/j.issn.1006-9771.2019.12.011
Previous Articles Next Articles
ZHAO Xiao-hua1,2, ZHOU Rui-han1,2, GUO Wei3, PANG Ri-zhao2, WANG Wen-chun2, ZHANG An-ren2
Received:2019-05-13
Revised:2019-06-03
Published:2019-12-25
Online:2019-12-26
Contact:
ZHANG An-ren, E-mail: 1518526780@qq.com
E-mail:1518526780@qq.com
Supported by:CLC Number:
ZHAO Xiao-hua, ZHOU Rui-han, GUO Wei, PANG Ri-zhao, WANG Wen-chun, ZHANG An-ren. Potential Impact of Gut Microbiota on Spinal Cord Injury (review)[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2019, 25(12): 1434-1438.
| 1 IhalainenT, Rinta KiikkaI, LuotoT M, et al. Traumatic cervical spinal cord injury: a prospective clinical study of laryngeal penetration and aspiration [J]. Spinal Cord, 2017, 55(11): 979-984. 2 Spinal Cord Injury (SCI) 2016 Facts and Figures at a Glance [J]. J Spinal Cord Med,2016, 39(4): 493-494. 3 SenderR, FuchsS, MiloR. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans [J]. Cell, 2016, 164(3): 337-340. 4 HollisterE B, GaoC, VersalovicJ. Compositional and functional features of the gastrointestinal microbiome and their effects on human health [J]. Gastroenterology, 2014, 146(6): 1449-1458. 5 ZuX P, LinZ, XieH S, et al. Interaction of effective ingredients from traditional Chinese medicines with intestinal microbiota [J]. Zhongguo Zhong Yao Za Zhi, 2016, 41(10): 1766-1772. 6 KirbyT O, Ochoa-RepárazJ. The gut microbiome in multiple sclerosis: a potential therapeutic avenue [J]. Med Sci (Basel), 2018, 6(3): 69-89. 7 LeeY K, MenezesJ S, UmesakiY, et al. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis [J]. Proc Natl Acad Sci U S A, 2011, 108(Suppl 1): 4615-4622. 8 PistollatoF, Sumalla CanoS, ElioI, et al. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease [J]. Nutr Rev, 2016, 74(10): 624-634. 9 SampsonT, DebeliusJ, ThronT, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease [J]. Cell, 2016, 167(6): 1469-1480. 10 KigerlK A, MostacadaK, PopovichP G. Gut microbiota are disease-modifying factors after traumatic spinal cord injury [J]. Neurotherapeutics, 2017, 15(1): 60-67. 11 HylandN P, CryanJ F. Microbe-host interactions: influence of the gut microbiota on the enteric nervous system [J]. Dev Biol, 2016, 417(2): 182-187. 12 ObataY, PachnisV. The Effect of microbiota and the immune system on the development and organization of the enteric nervous system [J]. Gastroenterology, 2016, 151(5): 836-844. 13 YooB B, MazmanianS K. The enteric network: interactions between the immune and nervous systems of the gut [J]. Immunity, 2017, 46(6): 910-926. 14 TaoY, NioushaA, SchmidtJ T, et al. Shifts in the gut microbiota composition due to depleted bone marrow beta adrenergic signaling are associated with suppressed inflammatory transcriptional networks in the mouse colon [J]. Front Physiol, 2017, 8: 220-235. 15 WilliamsE K, ChangR B, StrochlicD E, et al. Sensory neurons that detect stretch and nutrients in the digestive system [J]. Cell, 2016, 166(1): 209-221. 16 MargolisK G, GershonM D, BogunovicM. Cellular organization of neuroimmune interactions in the gastrointestinal tract [J]. Trends Immunol, 2016, 37(7): 487-501. 17 O'ConnorG, JeffreyE, MadormaD. Investigation of microbiota alterations and intestinal inflammation post-spinal cord injury in rat model [J]. J Neurotrauma, 2018, 35(18): 2159-2166. 18 GungorB, AdiguzelE, GurselI, et al. Intestinal microbiota in patients with spinal cord injury [J]. PLoS One, 2016, 11(1): e0145878- e0145888. 19 ZhangC, ZhangW, ZhangJ, et al. Gut microbiota dysbiosis in male patients with chronic traumatic complete spinal cord injury [J]. J Transl Med, 2018, 16(1): 353-369. 20 KigerlK A, HallJ C, WangL, et al. Gut dysbiosis impairs recovery after spinal cord injury [J]. J Exp Med, 2016, 213(12): 2603-2620. 21 BigfordG, NashM S. Nutritional health considerations for persons with spinal cord injury [J]. Top Spinal Cord Inj Rehabil, 2017, 23(3): 188-206. 22 Gutiérrez-VázquezC, QuintanaF J. Regulation of the immune response by the aryl hydrocarbon receptor [J]. Immunity, 2018, 48(1): 19-33. 23 QuintanaF J, SherrD H. Aryl hydrocarbon receptor control of adaptive immunity [J]. Pharmacol Rev, 2013, 65(4): 1148-1161. 24 LiY, InnocentinS, DavidR, et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation [J]. Cell, 2011, 147(3): 629-640. 25 RothhammerV, MascanfroniI D, BunseL, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor [J]. Nat Med, 2016, 22(6): 586-597. 26 ShindeR, McGahaT L. The aryl hydrocarbon receptor: connecting immunity to the microenvironment [J]. Trends Immunol, 2018, 39(12): 1005-1020. 27 LeeH U, McPhersonZ E, TanB, et al. Host-microbiome interactions: the aryl hydrocarbon receptor and the central nervous system [J]. J Mol Med (Berl), 2016, 95(1): 29-39. 28 LamasB, RichardM L, LeducqV, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands [J]. Nat Med, 2016, 22(6): 598-605. 29 WangL, PeiS, HanL, et al. Mesenchymal stem cell-derived exosomes reduce A1 astrocytes via downregulation of phosphorylated NF-κB P65 subunit in spinal cord injury [J]. Cell Physiol Biochem, 2018, 50(4): 1535-1559. 30 LuY, YangY Y, ZhouM W, et al. Ketogenic diet attenuates oxidative stress and inflammation after spinal cord injury by activating Nrf2 and suppressing the NF-κB signaling pathways [J]. Neurosci Lett, 2018, 683: 13-18. 31 Bracchi-RicardV, LambertsenK L, RicardJ, et al. Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury [J]. J Neuroinflammation, 2013, 10(1): 869-885. 32 YooB B, MazmanianS K. The enteric network: interactions between the immune and nervous systems of the gut [J]. Immunity, 2017, 46(6): 910-926. 33 RaposoC, SchwartzM. Central nervous system repair requires both effector and regulatory T cells with distinct temporal and spatial profiles [J]. J Neuroimmunol, 2014, 275(1-2): 206-207. 34 BlanderJ M, LongmanR S, IlievI D, et al. Regulation of inflammation by microbiota interactions with the host [J]. Nat Immunol, 2017, 18(8): 851-860. 35 ErnyD, Hrabě de AngelisA L, JaitinD, et al. Host microbiota constantly control maturation and function of microglia in the CNS [J]. Nat Neurosci, 2015, 18(7): 965-977. 36 WinekK, DirnaglU, MeiselA. The gut microbiome as therapeutic target in central nervous system diseases: implications for stroke [J]. Neurotherapeutics, 2016, 13(4): 762-774. 37 RooksM G, GarrettW S. Gut microbiota, metabolites and host immunity [J]. Nat Rev Immunol, 2016, 16(6): 341-352. 38 HustedA S, TrauelsenM, RudenkoO, et al. GPCR-mediated signaling of metabolites [J]. Cell Metab, 2017, 25(4): 777-796. 39 Camara-LemarroyC R, MetzL, MeddingsJ B, et al. The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics [J]. Brain, 2018, 141(7): 1900-1916. 40 HyunkyoungL, SoojinL, Ik-HyunC, et al. Toll-like receptors: sensor molecules for detecting damage to the nervous system [J]. Curr Protein Pept Sci, 2013, 14(1): 33-42. 41 RongY, LiuW, WangJ, et al. Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy [J]. Cell Death Dis, 2019, 10(5): 340-358. 42 XuS, ZhuW, ShaoM, et al. Ecto-5'-nucleotidase (CD73) attenuates inflammation after spinal cord injury by promoting macrophages/microglia M2 polarization in mice [J]. J Neuroinflammation, 2018, 15(1): 155-169. 43 KigerlK A, de Rivero VaccariJ P, DietrichW D, et al. Pattern recognition receptors and central nervous system repair [J]. Exp Neurol, 2014, 258: 5-16. 44 GoldsteinE Z, ChurchJ S, PukosN, et al. Intraspinal TLR4 activation promotes iron storage but does not protect neurons or oligodendrocytes from progressive iron-mediated damage [J]. Exp Neurol, 2017, 298: 42-56. 45 ChurchJ S, MilichL M, LerchJ K, et al. E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord [J]. Glia, 2017, 65(6): 883-899. 46 ChurchJ S, KigerlK A, LerchJ K, et al. TLR4 deficiency impairs oligodendrocyte formation in the injured spinal cord [J]. J Neurosci, 2016, 36(23): 6352-6364. 47 LinX, ZhaoT, WalkerM, et al. Transplantation of pro-oligodendroblasts, preconditioned by LPS-stimulated microglia, promotes recovery after acute contusive spinal cord injury [J]. Cell Transplant, 2016, 25(12): 2111-2128. 48 YiZ, YujieY, JiabaoG, et al. Abdominal manual therapy repairs interstitial cells of Cajal and increases colonic c-Kit expression when treating bowel dysfunction after spinal cord injury [J]. Biomed Res Int, 2017, 2017: 1-11. 49 RustR, KaiserJ. Insights into the dual role of inflammation after spinal cord injury [J]. J Neurosci, 2017, 37(18):4658-4660. 50 OkadaS. The pathophysiological role of acute inflammation after spinal cord injury [J]. Inflamm Regen, 2016, 36(1): 20-27. 51 DavidS, GreenhalghA D, KronerA. Macrophage and microglial plasticity in the injured spinal cord [J]. Neuroscience, 2015, 307(29): 311-318. 52 DiasD O, KimH, HollD, et al. Reducing pericyte-derived scarring promotes recovery after spinal cord injury [J]. Cell, 2018, 173(1): 153-165. 53 Coulson-ThomasV J, LauerM E, SolemanS, et al. Tumor necrosis factor-stimulated gene-6 (TSG-6) is constitutively expressed in adult central nervous system (CNS) and associated with astrocyte-mediated glial scar formation following spinal cord injury [J]. J Biol Chem, 2016, 291(38): 19939-19952. 54 ChenH, JiH, ZhangM, et al. An agonist of the protective factor SIRT1 improves functional recovery and promotes neuronal survival by attenuating inflammation after spinal cord injury [J]. J Neurosci, 2017, 37(11): 2916-2930. 55 YooJ Y, KimS S. Probiotics and prebiotics: present status and future perspectives on metabolic disorders [J]. Nutrients, 2016, 8(3): 173-193. 56 JuulF E, GarborgK, BretthauerM, et al. Fecal microbiota transplantation for primary clostridium difficile infection [J]. N Engl J Med, 2018, 378(26): 2535-2536. 57 GoldenbergJ Z, DominikM, JohnstonB C. Probiotics to prevent clostridium difficile infection in patients receiving antibiotics [J]. JAMA, 2018, 320(5): 499-501. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
||
